PCN5- FIRST-LINE THERAPY FOR ADVANCED BREAST CANCER - COST-EFFECTIVENESS OF ANASTROZOLE VERSUS TAMOXIFEN
Abstract
Authors
M Marchetti N Liberato G Barosi
M Marchetti N Liberato G Barosi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now